J&J settles a total of six lawsuits with Sheller, P.C. clients; hundreds more represented.

Sheller attorneys continue to accept new clients, but there will be a time limit for filing a claim. Contact us at 800-883-2299 or fill out the inquiry form on this page.

Injury Lawyer News is reporting on a mother that has filed a Risperdal gynecomastia lawsuit on behalf of her minor son, Injury Lawyer News, December 10, 2014The Simons Foundation Autism Research Initiative (SFARI) warns about the drug Risperidone, Simons Foundation Autism Research Initiative, April 28, 2014

Risperdal Suit Filings Increase in Phila. Court, The Legal Intelligencer, January 15, 2014

Lawyer Spars with FDA over J&J Risperdal Court Documents, Pharmalot, November 11, 2013 (Attorney Stephen Sheller’s strategy to hold J&J accountable profiled in pharmaceutical industry news)

University Researchers Are Seen As Enablers in Latest Drug Fraud, The Chronicle of Higher Education, November 8, 2013 (quotes Attorney Stephen Sheller saying the research gave a ‘misleading impression of the actual risk of breast development in boys)

J&J Balks on Deal to Settle U.S. Probe, The Wall Street Journal, May 9, 2013 (quotes Attorney Stephen Sheller on lawsuits involving boys and young men who developed gynecomastia while taking Risperdal)

Six Risperdal Suits to See Appeal Over Marketer’s Dismissal, Law360/LexisNexis, November 16, 2012

Johnson & Johnson settles six Risperdal boy breast lawsuits, hundreds of cases pending, CBS Moneywatch (PR Web distribution), October 10, 2012

Johnson & Johnson settles five Risperdal suits, The Philadelphia Inquirer, October 5, 2012

First Risperdal Trial Ends with Settlement, six cases total have settled in the litigation, The Legal Intelligencer, October 5, 2012

J&J resolves 5 Risperdal off-label cases, Law360/LexisNexis, October 4, 2012

Johnson & Johnson agrees to settle five Risperdal suits, Bloomberg Business Week, October 4, 2012

Former FDA Commish slams J&J over Risperdal, Pharmalot, October 4, 2012

J&J aims to block ex-FDA chief’s testimony in Risperdal case, Fierce Pharma, October 4, 2012

Ex-FDA chief David Kessler says J&J broke the law in promoting Risperdal, The Philadelphia Inquirer’s “PhillyPharma” blog, October 4, 2012

Lawsuit: Risperdal Schizophrenia Drug Makes Boys Grow Breasts, Law.com blog, October 2, 2012

Psychiatrist, plaintiff’s expert witness, testifies on third day of Philadelphia Risperdal trial, The Pennsylvania Record, Pennsylvania’s Legal Journal, September 28, 2012

Mother asks judge to release J&J report, wants jurors to see, The Philadelphia Inquirer, September 28, 2012

‘Risperdal Popcorn’ – Part of Day 2 of Philly Trial, The Philadelphia Inquirer’s “PhillyPharma” blog, September 26, 2012

Witness: J&J aimed Risperdal pitch at childrens’ doctors, Fierce Pharma, September 26, 2012

Products liability trial in Risperdal case opens in Philadelphia, The Legal Intelligencer, September 25, 2012 (PDF of newspaper)

Janssen promoted Risperdal off label, jury hears, Law360/LexisNexis, September 25, 2012

J&J pushed Risperdal with golf, popcorn, witness says, Bloomberg News, September 25, 2012

Risperdal trial: Sales rep cites pressure from above, The Philadelphia Inquirer, September 25, 2012

J&J lawyers to jury: What Risperdal popcorn?, Pharmalot, September 25, 2012

Risperdal caused teen boy’s breast growth, jury hears, Law360/LexisNexis, September 24, 2012

Chasing the press out of the room? A Q&A with Philadelphia Inquirer David Sell about his experience with J&J lawyers attempting to remove him from Risperdal trial jury selection, Pharmalot, September 21, 2012

Philly judge stops J&J attempt to bar Inquirer reporter, The Philadelphia Inquirer’s “PhillyPharma” blog, September 21, 2012

Johnson & Johnson CEO will not have to testify in Risperdal drug case, The Philadelphia Inquirer & Bloomberg Business Week, September 21, 2012

J&J’s Alex Gorsky testify? Much too busy . . . on the other side of the planet, The Philladelphia Inquirer’s “PhillyPharma” blog, September 19, 2012

Lawyers seek to force J&J chief onto the stand in Risperdal case, Fierce Pharma, September 19, 2012

Risperdal mass tort case settles in Phila. on first day of trial, The Pennsylvania Record, Pennsylvania’s Legal Journal, September 19, 2012

J&J’s CEO Should Be Forced to Testify, Teen’s Lawyers Say, Bloomberg, September 18, 2012

Lawyers in Risperdal case argue Johnson & Johnson’s CEO should be called to testify, Asbury Park Press/NJ.com, September 18, 2012

Lawyers for Teen Boy Say J&J CEO Should Be Forced to Testify, Pharmalot, September 18, 2012

Attys Want J&J CEO to Testify in Risperdal Breast Growth Case, Law360/LexisNexis, September 18, 2012

J&J CEO Gorsky talks Risperdal, via deposition, with lawyers nearby, The Philladelphia Inquirer’s “PhillyPharma” blog, September 19, 2012

J&J Settles Suit Over Risperdal and Male Breasts, PharmaLot.com, September 11, 2012

Johnson and Johnson settles Risperdal side effects lawsuit, The Philadelphia Inquirer, September 11, 2012

J&J settles Risperdal male breasts case on first day
, Pharma Times Online, September 11, 2012

J&J Sees Male Breasts and Quickly Settles Risperdal Suit, Forbes, September 11, 2012

J&J Settles Risperdal Lawsuit on Opening Day of Trial, Bloomberg Business Week, September 10, 2012

Johnson & Johnson settles on first day of Philly Risperdal trial
, The Philladelphia Inquirer & “PhillyPharma” blog, September 10, 2012

J&J Settles Lawsuit Alleging Injury from Antipsychotic, The Wall Street Journal/Dow Jones Newswire, September 10, 2012

J&J Settles PA Risperdal Lawsuit on Opening Day of Trial, Law 360/LexisNexis, September 10, 2012

J&J settles after plaintiff says drug caused him to grow breast tissue, Asbury Park Press, September 10, 2012

News Coverage: